Alpine Woods Capital Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Alpine Woods Capital Investors's BMY Position: Q2 2026 in Review
Alpine Woods Capital Investors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 16,000 shares worth $922K. The stake represents 0.2% of the portfolio and ranks #100 among its holdings.
2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Alpine Woods Capital Investors held 16,000 shares of Bristol-Myers Squibb worth $922K as of Q2 2026.
- Bristol-Myers Squibb was a new Alpine Woods Capital Investors position in Q2 2026.
- Bristol-Myers Squibb made up 0.2% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #100 holding.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.